Think there are no investment opportunities in stem cell research? Think again!
Did you know that even without any FDA approvals this year, stem cell product shipments in 2008 are on track to rise to $87 million? In fact the field is growing so quickly that on Tuesday many of the firms currently racing to the forefront of this science met in New York City at the 4th annual Stem Cell Summit.
Considering it's widely believed that President Obama will soon issue an executive order lifting the ban on federal funding for embryonic stem-cell research -- what's the trade?
Geron is the name many traders talk about as a leader in stem cell research, says Pete Najarian. However, it’s important to keep in mind that major breakthroughs are probably a way out, still.
In the larger space I like Celgene, Genzyme and Teva for their pipelines. Or if you don’t want to play stock picker, you can get broad exposure with the SPDR S&P Biotech ETF.
Or you can play the iShares NASDAQ Biotechnology Index ETF , adds Karen Finerman.
Personally, my favorite stock in the space is Celgene, adds Guy Adami.
Got something to to say? Send us an e-mail at email@example.com and your comment might be posted on the Rapid Recap. If you'd prefer to make a comment but not have it published on our website send your e-mail to firstname.lastname@example.org.
Trader disclosure: On Feb. 17th, 2008, the following stocks and commodities mentioned or intended to be mentioned on CNBC’s Fast Money were owned by the Fast Money traders; Seymour Owns (AAPL), (AA), (BAC), (EEM), (XOM), (FXI), (YUM); Seymour's Firm Owns (VIP); Adami Owns (AGU), (BTU), (C), (GS), (INTC), (MSFT), (NUE); Najarian Owns (CELG), (ENER); Najarian Owns (GS) Calls; Najarian Owns (EEM) Call Spread; Najarian Owns (FCX) & (FCX) Calls; Najarian Owns (CHK) Put Spread; Najarian Owns (GDX) Call Spread; Najarian Owns (GLD) Call Spread; Najarian Owns (MSFT) & (MSFT) Short Calls; Najarian Owns (MS) & (MS) Short Calls; Najarian Owns (MOS) Call Spread; Najarian Owns (STI) Call Spread; Finerman's Firm Owns (AET), (CRXL), (MSFT), (XBI), (FL); Finerman's Firm Owns (DNA) & (DNA) Call Spread; Finerman's Firm Is Short (USO), (VNO), (BBT), (IYR), (IJR), (IWM), (MDY), (SPY)